Corcept Therapeutics Incorporated shares owned by Arrowstreet Capital, Limited Partnership
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Arrowstreet Capital, Limited Partnership
from 13F filings
Historical chart of Arrowstreet Capital, Limited Partnership investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Arrowstreet Capital, Limited Partnership consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Arrowstreet Capital, Limited Partnership
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $31M | 369k | 83.11 |
| 2025-06-30 | $58M | 789k | 73.40 |
| 2025-03-31 | $170M | 1.5M | 114.22 |
| 2024-12-31 | $83M | 1.6M | 50.39 |
| 2024-09-30 | $73M | 1.6M | 46.28 |
| 2024-06-30 | $48M | 1.5M | 32.49 |
| 2024-03-31 | $43M | 1.7M | 25.19 |
| 2023-12-31 | $36M | 1.1M | 32.48 |
| 2023-09-30 | $30M | 1.1M | 27.25 |
| 2023-06-30 | $6.3M | 283k | 22.25 |
| 2023-03-31 | $219k | 10k | 21.70 |
| 2022-12-31 | $468k | 23k | 20.31 |
| 2022-03-31 | $318k | 14k | 22.49 |
| 2021-12-31 | $9.7M | 491k | 19.80 |
| 2021-09-30 | $29M | 1.5M | 19.68 |
| 2021-06-30 | $14M | 636k | 22.00 |
| 2021-03-31 | $25M | 1.0M | 23.79 |
| 2020-12-31 | $27M | 1.0M | 26.16 |
| 2020-09-30 | $16M | 939k | 17.40 |
| 2020-06-30 | $16M | 931k | 16.82 |
| 2020-03-31 | $14M | 1.2M | 11.89 |
| 2019-12-31 | $17M | 1.4M | 12.10 |
| 2019-03-31 | $3.7M | 314k | 11.74 |
| 2018-12-31 | $3.0M | 223k | 13.36 |
| 2018-06-30 | $13M | 850k | 15.72 |
| 2018-03-31 | $14M | 836k | 16.45 |
| 2017-12-31 | $9.8M | 541k | 18.06 |
| 2017-09-30 | $12M | 624k | 19.30 |
| 2017-06-30 | $1.2M | 99k | 11.80 |
| 2017-03-31 | $2.6M | 233k | 10.96 |
More positions owned by Arrowstreet Capital, Limited Partnership
View all positions for Arrowstreet Capital, Limited Partnership
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated